Investment Type: Venture Capital
Portfolio 5
| Date | Name | Website | Total Raised | Location |
| - | Health Fid... | healthfidelity.com | - | United Sta... |
| - | kfxmedical.com | - | - | |
| - | Prevacept | prevacept.com | - | - |
| - | Mirabilis | mirabilismed.com | - | United Sta... |
| - | VTI | vtivision.com | $9.03M | United Sta... |
Mentions in press and media 11
| Date | Title | Description |
| 18.06.2013 | Mirabilis Medica Raises $7M | Mirabilis Medica, a Bothell, Washington-based developer of ultrasound technology for treatment of uterine fibroids, held a $7m initial closing on $7 as part of a series A-1 financing of up to $13m. The round, which was led by GSR Ventures, ... |
| 25.03.2013 | $9M Series B will help Minimally Invasive Devices expand, drive sales of lens-clearing tools for laparoscopes | During a laparoscopic surgery, there are multiple ways the image the surgeon sees can become obscured. Fogging of the lens can occur during the cold laparoscope’s initial insertion into the abdominal cavity, for example, and debris or smoke... |
| 10.02.2012 | Health Fidelity Closes Series A | MENLO PARK, CA, Health Fidelity has closed a Series A financing round led by Charter Life Sciences. Firm's platform allows healthcare enterprises to extract data. >> Click here for more funding data on Health Fidelity >> To ... |
| 10.02.2012 | Health Fidelity Closes Series A Financing | Health Fidelity, Inc., a Menlo Park, CA-based platform company that delivers data to drive applications in healthcare. has closed a Series A financing round of undisclosed amount led by Charter Life Sciences. The company intends to use the ... |
| 28.12.2010 | Minimally Invasive Devices raises $1.5M, eyes new product launches | Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems strive to recov... |
| 27.07.2010 | Great Lakes Pharmaceuticals closes $3 million Series B round | By Mary Vanac Great Lakes Pharmaceuticals Inc. closed a $3.1 million Series B equity offering led by Charter Life Sciences, the Palo Alto, Calif.-based venture capital firm with an office in Cincinnati. The company, formed by Case Western R... |
| 26.07.2010 | Great Lakes Pharmaceuticals raises $3.1M for catheter lock trial | The clinical-stage company in Beachwood, Ohio has been driven by infection rates related to central-line catheters, often used for chemotherapy or dialysis. The Centers for Disease Control and Prevention estimates 250,000 catheter-related b... |
| 11.05.2009 | Revascular adds $3M to clear arteries | Revascular Therapeutics, maker of a device that helps doctors clear blockages in major arteries, has tacked on $3 million to a second round of funding, bringing its total to $11 million, reports VentureWire. The Sunnyvale, Calif., company h... |
| - | Great Lakes Pharmaceuticals raises $3.1M for catheter lock trial | Great Lakes Pharmaceuticals Inc. has completed a $3.1 million Series B equity financing led by Charter Life Sciences, the Palo Alto, California venture capital firm with an office in Cincinnati, Ohio. Early Stage Partners in Cleveland also ... |
| - | $9M Series B will help Minimally Invasive Devices expand, drive sales of lens-clearing tools for laparoscopes | As the number of laparoscopic procedures being performed at hospitals and surgery centers outgrows the number of open surgeries, facilities are investing millions of dollars into equipment to improve these procedures, like high-definition o... |
Show more